SRSF9 and hepatocellular carcinoma: RBM45 downregulation suppresses hepatocellular carcinoma proliferation, while SRSF9 stabilizes oncogenic transcripts like DSN1, which correlates with lymph node metastasis and an advanced stage of CRC [35,36].